Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £113.74m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Publication of a Prospectus and Circular

4 Sep 2024 12:32

RNS Number : 9161C
Triple Point Venture VCT PLC
04 September 2024
Β 

4 September 2024

Β 

Triple Point Venture VCT plc

(the "Company")

PUBLICATION OF PROSPECTUS AND CIRCULAR

The Board of Triple Point Venture VCT plc is pleased to announce that the Company has issued a prospectus (the "Prospectus") relating to an offer for venture ordinary shares to raise Β£10 million (the "Offer")*, together with a circular (the "Circular") relating to the approval of an offer agreement in connection with the Offer, following approval of the Prospectus and Circular from the Financial Conduct Authority.

Β 

*If the Offer is oversubscribed it may be increased to Β£30 million at the discretion of the directors of the Company.

Β 

Pursuant to the Offer, the Company's fund manager, Triple Point Investment Management LLP ("TPIM"), will enter into an agreement with the Company (the "Offer Agreement"), which will constitute a related party transaction as defined by the UK Listing Rules as it is an agreement between the Company and its fund manager, falling within UK Listing Rule 8.2.1R.

Β 

Pursuant to the Offer Agreement, TPIM will be paid (the "Promoter Fee") up to an amount equal to 5.5% of the aggregate value of accepted applications for Venture Shares under the Offer, out of which TPIM will discharge all external costs, including initial commissions, and its own costs, in respect of the Offer, but excluding any initial and ongoing charges agreed between an authorised financial adviser and an investor. The Promoter Fee is required to be aggregated under the UK Listing Rules with the same fee that was payable by the Company to TPIM for promoting the offer for subscription that was launched by the Company on 22 September 2023.

Β 

The Offer is now open and is expected to close on 31 July 2025 unless fully subscribed at an earlier date. A copy of the Prospectus and Circular will shortly be submitted to the National Storage Mechanism located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism and may be viewed on the Triple Point website at: www.triplepoint.co.uk.

Β 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

Triple Point Investment Management LLP

(Investment Manager)

Tel: 020 7201 8989

Seb Wallace

Jack Rose

Β 

Β 

The Company's LEI is 213800AOOAQA5XQDEA89

Β 

Further information on the Company can be found on its websiteΒ https://www.triplepoint.co.uk/current-vcts/triple-point-venture-vct-plc/s2539/

Β 

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
PDILIMBTMTTMBPI
Date   Source Headline
29th Jun 202612:52 pmRNSFinal Results for the year ended 28 February 2026
25th Jun 20264:51 pmRNSTransaction in Own Shares
30th Apr 20262:14 pmRNSTotal Voting Rights
10th Apr 20261:20 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20264:09 pmRNSTotal Voting Rights
31st Mar 20264:05 pmRNSResult of General Meeting
31st Mar 20261:00 pmRNSIssue of Equity and Total Voting Rights
24th Mar 202612:13 pmRNSIssue of Equity and Total Voting Rights
23rd Mar 20267:00 amRNSOffer for Subscription - over-allotment facility
20th Mar 20264:41 pmRNSTransaction in Own Shares
18th Mar 20264:36 pmRNSIssue of Equity and Total Voting Rights
4th Mar 20264:42 pmRNSPublication of a Circular
27th Feb 20264:29 pmRNSTotal Voting Rights
27th Feb 20263:40 pmRNSIssue of Supplementary Prospectus
18th Feb 20265:02 pmRNSProposed Increase in Size of Offer
16th Feb 20262:31 pmRNSISSUE OF EQUITY AND TOTAL VOTING RIGHTS
13th Feb 20264:34 pmRNSOffer for Subscription - over-allotment facility
2nd Feb 20267:00 amRNSNet Asset Value(s)
12th Jan 20267:00 amRNSDividend Declaration
31st Dec 202512:20 pmRNSTotal Voting Rights
31st Dec 202512:20 pmRNSTotal Voting Rights
19th Dec 20257:00 amRNSVenture Share Class Net Asset Value
16th Dec 202512:10 pmRNSIssue of Equity and Total Voting Rights
1st Dec 202512:06 pmRNSIssue of Equity and Total Voting Rights
28th Nov 20259:30 amRNSOffer for Subscription - over-allotment facility
21st Nov 20253:46 pmRNSTransaction in Own Shares
12th Nov 20257:00 amRNSResults for the six months ended 31 August 2025
11th Nov 202511:20 amRNSIssue of Equity and Total Voting Rights
3rd Nov 202510:33 amRNSTotal Voting Rights
14th Oct 202511:14 amRNSIssue of Equity and Total Voting Rights
29th Sep 20257:00 amRNSDividend Declaration
5th Sep 202512:30 pmRNSPublication of a Prospectus
1st Sep 20253:09 pmRNSTotal Voting Rights
8th Aug 20253:23 pmRNSTransaction in Own Shares
4th Aug 20257:00 amRNSIntention to Launch an Offer for Subscription
1st Aug 20259:21 amRNSTotal Voting Rights
31st Jul 20251:27 pmRNSIssue of Equity and Total Voting Rights
30th Jul 20254:29 pmRNSVenture Share Class Net Asset Value
22nd Jul 202511:36 amRNSResult of AGM
4th Jul 20254:28 pmRNSTransaction in Own Shares
4th Jul 20251:16 pmRNSIssue of Equity and Total Voting Rights
25th Jun 20252:44 pmRNSOffer for Subscription - over-allotment facility
24th Jun 20254:36 pmRNSAnnual Financial Report and Notice of AGM
24th Jun 202512:29 pmRNSPublication of Supplementary Prospectus
16th Jun 20257:00 amRNSFinal Results for the year ended 28 February 2025
1st May 20252:58 pmRNSTotal Voting Rights
8th Apr 202510:24 amRNSIssue of Equity and Total Voting Rights
4th Apr 202512:28 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20251:11 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20251:33 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.